SynthesisGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Analysing myopia in Europe: A comprehensive meta-analysis.
Synthesis in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Screen Time and Myopia-Related Outcomes in European Children: A Systematic Review.Vision (Basel, Switzerland) · 2026Review
- Myopia Trends in Europe: A Reappraisal of Current Evidence.Ophthalmology and therapy · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This meta-analysis aimed to estimate the prevalence of myopia across European populations and assess its variation by age, region, gender, cycloplegic status, and urbanization. A total of 28 cross-sectional observational studies were included, comprising 347,651 individuals aged 4 to 99 years from various European countries. Studies were selected through systematic searches in PubMed, Web of Science, and Scopus, and assessed using the MINORS criteria. Meta-analytical methods included pooled prevalence estimates, subgroup analyses, and heterogeneity assessments. The overall prevalence of myopia in Europe was 24.88% (95% CI: 20.82-28.94; 95% PI 8.3-52.1; I²=100%), reflecting substantial heterogeneity among studies. Prevalence varied by age, ranging from 3.3% in children to 49.7% in adolescents, and by region, with higher rates in Northern (25.97%) and Southern Europe (23.58%) than in Eastern Europe (22.66%). Prevalence was similar between genders. Studies using cycloplegic refraction reported slightly lower myopia rates. Myopia prevalence was similar between urban (25.88%) and rural areas (26.96%). The prevalence of high myopia (SE ≤ -6.0 D) was 3.09% (95% CI: 2.2-3.96; 95% PI: 0.5-8.4; I²=100%). Myopia prevalence in Europe shows wide between-study variability but overall affects roughly one in four individuals, particularly adolescents and populations in certain regions. These findings underscore the influence of environmental and methodological factors and the importance of standardized diagnostic criteria. Targeted public health measures may help address the growing burden of myopia across Europe.
Indexed as
Identifiers
41420781What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.